Crosstalk Between Cancer‐Associated Fibroblasts and Immune Cells: Mechanisms and Therapeutic Implications
Open Access
- 14 December 2025
- journal article
- Published by Wiley in MedComm – Oncology
- Vol. 4 (4)
Abstract
Cancer‐associated fibroblasts (CAFs) in the tumor microenvironment (TME) interact with multiple immune cells, such as T cells, macrophages, neutrophils, and other immune cells, to display both antitumor or protumor effects. Despite enormous progress in immunotherapy, the CAF‐associated resistance of immunotherapy is still urgent to be solved. In this review, we summarize the origins and heterogeneity of CAFs in the TME, including the subpopulations of CAFs and their biological function. Then we discuss the communications between CAFs and tumor‐associated macrophages, T lymphocytes, tumor‐associated neutrophils, and other immune cells. CAFs cannot only recruit immune cells in the TME, but also trigger polarization, proliferation, infiltration of immune cells, thereby promoting tumor progression. Inversely, some immune cells promote the recruitment, transdifferentiation, and proliferation of CAFs. We also focus on the current progress in therapeutic strategies targeting CAF‐elimination, CAF‐reprograming, downstream signaling blockade, and CAF‐induced extracellular matrix barrier elimination to enhance the efficacy of immunotherapy and related clinical trials. Overall, we aim to provide the conceptions of CAF‐immunocyte crosstalk in the TME and application of immunotherapy, paving the way for the development of precise and individualized strategies through clarifying the interaction between CAFs and immunocytes.Keywords
This publication has 176 references indexed in Scilit:
- Cancer‐Associated Fibroblast‐Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma ProgressionHepatology, 2021
- Human fibronectin extra domain B as a biomarker for targeted therapy in cancerMolecular Oncology, 2020
- Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic CancerJAMA Oncology, 2019
- Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinomaThe Journal of Pathology, 2018
- T lymphocyte subsets in cancer immunity: Friends or foesJournal of Leukocyte Biology, 2018
- Contribution of regulatory T cells to cancer: A reviewJournal of Cellular Physiology, 2018
- Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma developmentThe Journal of Pathology, 2016
- A pro‐tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitmentThe Journal of Pathology, 2014
- VEGFR2 is selectively expressed by FOXP3high CD4+ TregEuropean Journal of Immunology, 2009
- Tumor‐associated fibroblasts recruit blood monocytes into tumor tissueEuropean Journal of Immunology, 2003